Rachel Garlick net worth
Quick answer
Rachel Garlick's estimated net worth is $10.0M (range $7.0M – $15.0M) as of 2026. Rachel Garlick is Founder at Eris Biotech. Eris Biotech valuation.
Rachel Garlick is Founder at Eris Biotech (YC W24). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Stanford University
- Region: United States of America
- Industries: Healthcare, Therapeutics
- Team size: 2
- Website: http://www.erisbio.com
Who is Rachel Garlick?
Rachel Garlick is a founder at Eris Biotech, which participated in Y Combinator's Winter 2024 batch.
Highlights:
- Stanford University
- Y Combinator
About Eris Biotech
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
FAQ: Rachel Garlick net worth and Eris Biotech valuation
What is Rachel Garlick's net worth?
Rachel Garlick's estimated net worth is $10.0M (range $7.0M – $15.0M) as of 2026. Rachel Garlick is Founder at Eris Biotech. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Eris Biotech valuation?
Eris Biotech's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Rachel Garlick's role?
Rachel Garlick is Founder at Eris Biotech, a Y Combinator-backed startup (batch W24).